Présentation de l'entreprise
INLIF Limited, operating under the ticker INLF, is a specialized manufacturer focused on the research, development, manufacture, and sale of injection molding machine-dedicated manipulator arms marketed under the iNLIF brand within the People's Republic of China. The enterprise operates within the Industrials sector, specifically the Specialty Industrial Machinery industry, positioning it as a provider of transverse single and double-axis manipulator arms designed for automated manufacturing environments. The company's market capitalization stands at $50.81M, supported by an annual trailing twelve-month revenue of $18.41M and a workforce consisting of 156 employees. These valuation figures indicate that INLIF is a small-cap entity with a relatively modest operational footprint compared to large-scale industrial conglomerates, reflecting its niche focus on dedicated automation hardware rather than diversified consumer goods or broad industrial services.
Santé financière
The company reported a revenue of $18.41M for the trailing twelve months, yet generated a net income of $-5,446,252 and an EBITDA of $-5,489,902, highlighting a significant gap between top-line sales and profitability driven by substantial operating losses. Despite the net loss, the entity maintained a positive free cash flow of $1.10M, which suggests a degree of financial flexibility allowing the company to fund operations or debt service without immediate external capital injections. The gross margin stands at 23.3%, indicating that the company retains a moderate portion of sales revenue after covering the direct costs of goods sold, while the operating margin of -46.1% and profit margin of -29.6% reveal that overhead costs and other expenses are consuming nearly half of the operating revenue before reaching the bottom line. The balance sheet displays $6.72M in cash against $4.97M in debt, resulting in a debt-to-equity ratio of 30.82, which points to a leveraged capital structure where equity capital is significantly lower than debt obligations. Liquidity is supported by a current ratio of 2.11, indicating that current assets are more than double current liabilities and providing a comfortable buffer for meeting short-term obligations. Return on Equity is recorded at -41.3% and Return on Assets at -16.8%, metrics that demonstrate that the company's current management actions are diluting shareholder value and utilizing assets inefficiently in terms of generating positive returns during this period.
Évaluation de la valorisation
Trailing P/E and forward P/E ratios are both listed as N/A due to the company's negative earnings, which implies that traditional earnings-based valuation multiples cannot be applied to assess future earnings trajectory or expected growth in profitability. The price-to-book ratio is 4.31, suggesting that the market values the company at a significant premium over its net asset value, potentially reflecting intangible assets, future growth potential, or investor sentiment that the current losses are temporary. Alternative valuation metrics such as the price-to-sales ratio of 2.76 and an EV/EBITDA of -8.94 provide context for valuation based on revenue and enterprise value relative to cash flow, though the negative EV/EBITDA underscores the lack of current earnings power. The stock has traded between a 52-week low of $3.58 and a 52-week high of $28.00, meaning the current trading price sits in a wide range relative to this historical volatility. The beta is listed as N/A, which prevents a direct quantification of the stock's price volatility relative to the broader market, though the extensive price swing between $3.58 and $28.00 inherently indicates high sensitivity to market conditions.
Growth & Income
Revenue growth year-over-year declined by 10.2%, while earnings growth is N/A due to the absence of prior period profitability, indicating that the company is currently in a contractionary phase regarding top-line sales rather than experiencing profitable expansion. As the company does not distribute dividends, there is a dividend yield of N/A and a payout ratio of 0.0%, meaning all earnings, had they been positive, would be reinvested into growth initiatives rather than distributed to shareholders. The absence of dividend payments combined with negative earnings growth suggests the company is prioritizing capital retention to address its operational losses and fund its manufacturing operations in China. Overall, the growth and income profile is characterized by negative revenue momentum and a lack of current income generation, requiring external capital or operational turnaround to restore positive cash conversion and profitability.